Previous 10 | Next 10 |
SAN DIEGO , Nov.14, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including prostate, colorect...
Trovagene (NASDAQ: TROV ): Q3 GAAP EPS of -$0.71 beats by $0.13 . More news on: TrovaGene, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SAN DIEGO , Nov. 7, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including prostate, color...
SAN DIEGO , Nov. 6, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, prosta...
TrovaGene (NASDAQ: TROV ) is off 2.8% postmarket after shareholders filed to offer up to 8.48M shares . More news on: TrovaGene, Inc., Healthcare stocks news, Stocks on the move Read more ...
Gainers: Tiffany & Co. (NYSE: TIF ) +31% . Xunlei Limited (NASDAQ: XNET ) +27% . Datasea (NASDAQ: DTSS ) +25% . comScore (NASDAQ: SCOR ) +24% . Fitbit (NYSE: FIT ) +23% . Aquestive Therapeutics (NASDAQ: AQST ) +23% . ChinaNet Online Holdings (NASDAQ: CNET ) +20% . Libbey (...
SAN DIEGO , Oct. 25, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including prostate, colorectal ...
Gainers: Lightbridge Corporation (NASDAQ: LTBR ) +19% . Sesen Bio (NASDAQ: SESN ) +17% . Visteon Corporation (NASDAQ: VC ) +17% . Tesla (NASDAQ: TSLA ) +17% . Rigel Pharmaceuticals (NASDAQ: RIGL ) +17% . TrovaGene (NASDAQ: TROV ) +16% . Contango Oil & Gas Company (NYSEMKT: ...
Resideo Technologies (NYSE: REZI ) -42% on announcing preliminary Q3 results, 2019 outlook and CFO transition . More news on: Resideo Technologies, Inc., Midatech Pharma plc, iRobot Corporation, Stocks on the move, Read more ...
Gainers: TrovaGene (NASDAQ: TROV ) +65% . Biogen (NASDAQ: BIIB ) +29% . Stamps.com (NASDAQ: STMP ) +24% . Teekay Corporation (NYSE: TK ) +22% . Cision (NYSE: CISN ) +19% . Teekay LNG Partners (NYSE: TGP ) +17% . Obalon Therapeutics (NASDAQ: OBLN ) +14%. Athenex (NASDAQ: ...
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO , May 7, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including colorectal cancer, prostate cancer and leukemia, today a...
SAN DIEGO , May 6, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company developing its drug, onvansertib, to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, Zytiga&...
SAN DIEGO , April 28, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including colorectal cancer, prostate cancer and leukemia, ...